Form 4: Axogen Director Gregory Freitag Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Gregory Freitag reports accelerated vesting of restricted stock units resulting in changes in beneficial ownership of Axogen, Inc. shares.
Summary
- On June 4, 2024, Axogen, Inc. Director Gregory Freitag reported a transaction involving the vesting of restricted stock units.
- The Board of Directors accelerated the vesting of 11,904 shares of common stock.
- Following the transaction, Freitag directly owns 283,498 shares of Axogen, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the sentiment is neutral as it simply reports a transaction.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the equity holdings of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of the transaction involving the vesting of restricted stock units and acceleration of vesting of common stock. |
| 06/06/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.